Cargando…
Medication use review: does it have a future and potential in Latvia? The opinion of pharmacists after the pilot project
BACKGROUND: Given that the Medication Use Review (MUR) can be used as a tool to improve the quality, safety, and appropriate use of medications, it has been implemented in several countries around the world. The MUR pilot project was carried out in Latvia, followed by this study to identify obstacle...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044426/ https://www.ncbi.nlm.nih.gov/pubmed/36973735 http://dx.doi.org/10.1186/s40545-023-00551-2 |
_version_ | 1784913355448778752 |
---|---|
author | Paidere, Madara Pavlovska, Jūlija Rutkovska, Ieva Ķikute, Dace Salmane-Kuļikovska, Ieva |
author_facet | Paidere, Madara Pavlovska, Jūlija Rutkovska, Ieva Ķikute, Dace Salmane-Kuļikovska, Ieva |
author_sort | Paidere, Madara |
collection | PubMed |
description | BACKGROUND: Given that the Medication Use Review (MUR) can be used as a tool to improve the quality, safety, and appropriate use of medications, it has been implemented in several countries around the world. The MUR pilot project was carried out in Latvia, followed by this study to identify obstacles, favorable factors, and benefits of this service from the perspective of pharmacists, being one of the key stakeholders. METHODS: Qualitative data were obtained through a semi-structured focus group interview with pharmacists participating in the project. Inductive thematic analysis was performed on transcript to describe potential gains, obstacles, and prerequisites for implementing the MUR service from the pharmacist’s perspective. RESULTS: Lack of payment, cooperation with physicians, problems with patient involvement and insufficiency of competence, were identified as the main barriers to implementation of the MUR service as a pharmacist-led service in community pharmacy. However, there were also contributing factors for MUR service, such as the interest of patients and pharmacists involved in the project, the support from the employer, the benefit for physicians, the improvement of patient health literacy and medication adherence. CONCLUSIONS: Despite the potential obstacles, the findings in Latvia, as well as other countries, show that the MUR service contributes to the benefit of patients, pharmacists and also physicians; therefore, further steps should be taken to eliminate obstacles and gain additional insights to implement the MUR service in Latvia. |
format | Online Article Text |
id | pubmed-10044426 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-100444262023-03-29 Medication use review: does it have a future and potential in Latvia? The opinion of pharmacists after the pilot project Paidere, Madara Pavlovska, Jūlija Rutkovska, Ieva Ķikute, Dace Salmane-Kuļikovska, Ieva J Pharm Policy Pract Research BACKGROUND: Given that the Medication Use Review (MUR) can be used as a tool to improve the quality, safety, and appropriate use of medications, it has been implemented in several countries around the world. The MUR pilot project was carried out in Latvia, followed by this study to identify obstacles, favorable factors, and benefits of this service from the perspective of pharmacists, being one of the key stakeholders. METHODS: Qualitative data were obtained through a semi-structured focus group interview with pharmacists participating in the project. Inductive thematic analysis was performed on transcript to describe potential gains, obstacles, and prerequisites for implementing the MUR service from the pharmacist’s perspective. RESULTS: Lack of payment, cooperation with physicians, problems with patient involvement and insufficiency of competence, were identified as the main barriers to implementation of the MUR service as a pharmacist-led service in community pharmacy. However, there were also contributing factors for MUR service, such as the interest of patients and pharmacists involved in the project, the support from the employer, the benefit for physicians, the improvement of patient health literacy and medication adherence. CONCLUSIONS: Despite the potential obstacles, the findings in Latvia, as well as other countries, show that the MUR service contributes to the benefit of patients, pharmacists and also physicians; therefore, further steps should be taken to eliminate obstacles and gain additional insights to implement the MUR service in Latvia. BioMed Central 2023-03-27 /pmc/articles/PMC10044426/ /pubmed/36973735 http://dx.doi.org/10.1186/s40545-023-00551-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Paidere, Madara Pavlovska, Jūlija Rutkovska, Ieva Ķikute, Dace Salmane-Kuļikovska, Ieva Medication use review: does it have a future and potential in Latvia? The opinion of pharmacists after the pilot project |
title | Medication use review: does it have a future and potential in Latvia? The opinion of pharmacists after the pilot project |
title_full | Medication use review: does it have a future and potential in Latvia? The opinion of pharmacists after the pilot project |
title_fullStr | Medication use review: does it have a future and potential in Latvia? The opinion of pharmacists after the pilot project |
title_full_unstemmed | Medication use review: does it have a future and potential in Latvia? The opinion of pharmacists after the pilot project |
title_short | Medication use review: does it have a future and potential in Latvia? The opinion of pharmacists after the pilot project |
title_sort | medication use review: does it have a future and potential in latvia? the opinion of pharmacists after the pilot project |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044426/ https://www.ncbi.nlm.nih.gov/pubmed/36973735 http://dx.doi.org/10.1186/s40545-023-00551-2 |
work_keys_str_mv | AT paideremadara medicationusereviewdoesithaveafutureandpotentialinlatviatheopinionofpharmacistsafterthepilotproject AT pavlovskajulija medicationusereviewdoesithaveafutureandpotentialinlatviatheopinionofpharmacistsafterthepilotproject AT rutkovskaieva medicationusereviewdoesithaveafutureandpotentialinlatviatheopinionofpharmacistsafterthepilotproject AT kikutedace medicationusereviewdoesithaveafutureandpotentialinlatviatheopinionofpharmacistsafterthepilotproject AT salmanekulikovskaieva medicationusereviewdoesithaveafutureandpotentialinlatviatheopinionofpharmacistsafterthepilotproject |